Business Wire

UniPrint Partners with Healthcare IT Security Leader, Imprivata, to Enable Clinicians To Securely Print Protected Health Information

Del

UniPrint.net Corp., the world leader in printing virtualization, today announced a partnership with Imprivata®, the healthcare IT security company. UniPrint.net has joined the Imprivata Developer Partner (IDP) program, utilizing the Imprivata OneSign® Print Connector to establish connectivity between UniPrint’s™ patented Universal Printer Driver and Virtual Print Queue, and Imprivata OneSign. This integrated solution enables clinicians that use virtual desktops, to securely and conveniently print Protected Health Information (PHI) to any printer, by using the same proximity card they use to log in and securely access patient data. The joint solution increases security and compliance for healthcare providers by eliminating the printing of private health information on unattended printers.

Traditionally, location-based printing has been a challenge for even the most efficient hospitals. Healthcare professionals may inadvertently send prescriptions and private patient data to print on the wrong printer or a printer in a different facility, potentially exposing PHI and violating regulatory requirements.

David Fung, CEO of UniPrint.net comments, “Imprivata OneSign streamlines access, giving healthcare providers increased productivity, better compliance, stronger security, and reduced IT costs. Caregivers can now spend more time with patients and less time signing on to systems. When Imprivata OneSign is deployed in a virtual environment, a user’s desktop follows them as they roam around the workplace. An essential part of that workflow optimization is enabling secure, on demand printing to the correct printer. With a proven track record in healthcare, UniPrint is ideally suited to provide mobile healthcare workers with the ability to conveniently and securely print documents.”

Imprivata OneSign gives millions of care providers fast and secure No Click Access® to the applications and patient information they need, whenever and wherever they need it. By integrating with the

Imprivata OneSign Print Connector, UniPrint’s Universal Printer Driver and Virtual Print Queue leverages Imprivata OneSign’s clinical identity and authentication policy management capabilities and offers error-free, secure mobile printing on demand. Clinicians can print their documents using the same proximity card they use to securely access any endpoint and patient records.

“When healthcare providers are dealing with confidential patient information, they need a trusted, proven solution to address their secure printing needs,” said Clay Ritchey, Chief Marketing Officer at Imprivata. “Printing is often an overlooked vulnerability in healthcare organizations and we’re pleased that UniPrint is able to provide the secure printing workflow within Imprivata OneSign to add another layer of security for our joint customers.”

The solution will be introduced at the upcoming VMworld Conference in Las Vegas, USA, August 28-31. Come by the UniPrint Booth #657 to view a product demo, or to the Imprivata Booth #862 for additional information. Alternatively, visit www.uniprint.net to learn more about UniPrint.net, or book a free demo of our Healthcare Printing Suite.

About UniPrint.net:
UniPrint.net is the recognized leader in printing virtualization. The newest solution in UniPrint’s patented, award-winning product line, UniPrint Infinity is the industry’s first truly secure enterprise-wide solution for any computing environment. Enabling anywhere, anytime, and any device secure pull printing, UniPrint Infinity comes with a proven ROI through its statistics module, print document archiving functionality, secure mobile printing modules, and high availability setup with load balancing capability. UniPrint Infinity replaces all manufacturer printer drivers with a single PDF generator to promote faster, more efficient printing, helping organizations to improve both productivity and return on investments.

UniPrint™ and UniPrint Infinity™ are the trademarks of UniPrint.net Corp. All other trademarks and registered trademarks are properties of their respective owners.

About Imprivata:
Imprivata® (NYSE: IMPR), the healthcare IT security company, provides healthcare organizations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications, and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate, and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. For more information, please visit www.imprivata.com.

Contact information

UniPrint.net
Katherine Cheung, +1-416-503-9800 x 8586
Marketing Manager
Katherine.cheung@uniprint.net
or
Imprivata
John Hallock, 617-615-7712
jhallock@imprivata.com
or
Imprivata
Kerry Pillion, 781-761-1452
kpillion@imprivata.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Announcement by Viking Corp on Tecnotree22.6.2018 11:09Pressemelding

In the interests of stakeholder transparency, this announcement provides background and context to Viking's file bankruptcy proceedings upon Tecnotree: As many of you will now know, Viking Corp was recently forced to file bankruptcy proceedings upon Tecnotree, which were withdrawn on the 19 June. In the interests of stakeholder transparency, we make this Announcement to provide background and context to this action. Firstly, we would reflect on the recent history of our attempts to partner with Tecnotree and all its stakeholders. Viking launched a Tender Offer (TO), having conducted detailed discussions with the Tecnotree Board and our advisors. On the basis of those discussions, we were very confident that the TO price of 10 cents per share provided truly superior value for shareholders. So did the Tecnotree Board as evidenced by their unanimous recommendation of our Offer and of course, further evidenced by the current prevailing market price. This TO was supported in the most vigoro

HeartSciences Named “Start-Up to Watch”22.6.2018 11:00Pressemelding

HeartSciences is delighted to have been highlighted as “Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist. The article titled “HEARTSCIENCES: ARTIFICIAL INTELLIGENCE IMPROVES FRONTLINE RISK STRATIFICATION FOR HEART DISEASES” discusses HeartSciences’ role in addressing the current challenges and significant unmet need to identify heart disease at an early stage and reduce the high prevalence of expensive diagnostic testing with low yields. The article highlights the enormous opportunity for HeartSciences’ breakthrough MyoVista® Wavelet ECG (wavECG™) technology to benefit patients and to reduce health system costs and references a recently published study titled “Prediction of Abnormal Myocardial Relaxation From Signal Processed Surface ECG” in the Journal of American College of Cardiology (JACC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005088/en/ MyoVista Wavelet ECG Cardiac Testing Device (P

High-Performance Solutions and Complete Protection for Critical Installations: the Latest Innovations from CNIM and Its Bertin Subsidiary to Be Unveiled at WNE 201822.6.2018 09:39Pressemelding

The third edition of the World Nuclear Exhibition – major event for the global nuclear energy community – will be held at Paris-Villepinte, June 26 th to 28 th , 2018. CNIM and Bertin Technologies , leading players in the fields of nuclear equipment, safe handling and instrumentation for the complete protection of nuclear power plants, will be unveiling their joint offerings at this exhibition (booth D125-Hall 7). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005185/en/ CNIM's high safety fuel handling systems (Photo: Business Wire) Based on its long experience of major nuclear projects and its cutting-edge industrial capabilities, CNIM’s offering reflects its ability to innovate and adapt to the most difficult environments. Highlights on its exhibition booth will include: The design and manufacturing of high-safety fuel handling systems (notably the design of three remotely operated spent fuel handling and transferri